NSE · KRONOX
Kronox Lab Sciences Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹103 Cr with net profit ₹25 Cr — a 24.79% net margin, versus 23.35% the period before.
Shareholding
As of 2026-06-30
- Promoter74.21%
- Public23.67%
- FII0.04%
- DII2.07%
32,479 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.96× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Specialty Chemicals · ranked #6 of 18 by market cap · medians across 8 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Kingfa Science & Technology (India) Ltd. | ₹6,844 Cr | 36.94 | 4.89 | 13.24% | 9.28% |
| Paushak Limited | ₹1,436 Cr | 114.88 | 2.92 | 8.01% | 17.99% |
| Sudarshan Colorants India Ltd. | ₹835 Cr | 63.6 | 1.46 | 7.81% | 5.7% |
| Kothari Petrochemicals Ltd. | ₹817 Cr | 11.24 | 2.2 | 19.47% | 12.26% |
| Premier Polyfilm Ltd. | ₹771 Cr | 89.76 | 5.27 | 21.66% | 9.59% |
| Kronox Lab Sciences Ltd.(this company) | ₹571 Cr | 20.67 | 4.92 | 23.82% | 27.22% |
| Plastiblends India Ltd. | ₹487 Cr | 35.19 | 1.08 | 8.17% | 5.27% |
| Poddar Pigments Limited | ₹271 Cr | 57.14 | 0.76 | 4.21% | 3.45% |
| Seya Industries Limited | ₹33 Cr | — | 0.04 | -35.12% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashKronox Lab Sciences Ltd. manufactures and sells fine chemicals, inorganic chemicals, phosphates, and metallic chemicals in India and internationally. The company provides bulk reagents, bulk ingredients, and specialty chemicals. Incorporated in 2008, Kronox Lab Sciences Limited is based in Vadodara, India, and has a market capitalization of Rs 552 Cr. The company reported revenue of Rs 101.22 Cr.
Positives
- +The company has zero debt, with a debt-to-equity ratio of 0.
- +Promoter holding is high at 74.21% as of June 30, 2026, with no shares pledged.
- +The profit margin is 27.22%, indicating strong operational efficiency.
- +Return on Capital Employed (ROCE) is 31.78%, and Return on Equity (ROE) is 23.82%.
Negatives
- −Revenue growth for the latest annual period is not available, making it difficult to assess top-line expansion.
- −Quarterly EPS figures are consistently null across all reported quarters.
- −FII holding is very low at 0.04% as of June 30, 2026.
- −The number of shareholders decreased from 39,792 in September 2024 to 32,479 in June 2026.
Business Overview
Kronox Lab Sciences Limited operates in the Basic Materials sector, specializing in the production and sale of various chemicals. Its product portfolio includes bulk reagents such as ACS, LR, AR, and GR reagents, alongside bulk ingredients for diverse applications including oral care, pharmacopoeia, food and nutraceutical, personal care, cosmetics, and veterinary pharma. Additionally, the company offers specialty chemicals like tartrates, citrates, hypophosphites, phosphates, and ultra-high purity chemicals.
Financial Performance
Kronox Lab Sciences Ltd. reported a revenue of Rs 101.22 Cr. The annual net profit increased from Rs 21.35 Cr in March 2024 to Rs 25.47 Cr in March 2025. Similarly, EBITDA rose from Rs 28.61 Cr in March 2024 to Rs 34.27 Cr in March 2025. Quarterly net profit stood at Rs 8 Cr in March 2026, compared to Rs 6.59 Cr in December 2025.
Profitability & Returns
The company recorded a profit margin of 27.22%. Return on equity (ROE) was 23.82%, and return on capital employed (ROCE) stood at 31.78%. Earnings per share (EPS) for the latest available annual period was Rs 7.45. Quarterly EPS data is not available.
Balance Sheet
Kronox Lab Sciences Ltd. has a debt-to-equity ratio of 0, indicating no debt. The book value per share is Rs 31.3. No other specific balance sheet figures are available in the provided data.
Ownership & Pledges
As of June 30, 2026, promoters held 74.21% of the shares. Public shareholding was 23.67%, while DIIs held 2.07% and FIIs held 0.04%. Total institutional holding (DII + FII) stood at 2.12%. There were no shares pledged by the promoters.
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.